Ever expanding rapid diagnostic products

Inverness Medical Innovations develops and manufactures rapid diagnostic products for use in preventive as well as interventional therapies.

Information from patients’ body fluids, or tissue, assists physicians to diagnose disease, as well as to measure a patient’s response to a specific therapy. Its range of clinical diagnostic products already includes, the well-known brands Clearview, Inverness Medical TestPack, Binax, Determine, BioStar, and many others. ‘Our high quality immunoassays in pregnancy testing and fertility, respiratory, enteric and infectious diseases, autoimmune disorders, osteoporosis, cancer and cardiology, have demonstrated proven efficiency in clinics, hospitals and laboratories internationally,’ the firm points out.

Currently, Inverness Medical Innovations reports that it is exploring opportunities to optimise the use of its technologies, as well as continually evaluating other technological advances, for development or acquisition, in a variety of medical/health areas.

14.11.2006

News • Rapid diagnostics

New system simultaneously detects antibiotic resistence and virulence of K. pneumoniae

Now, a research team has developed a novel diagnostic approach that enables the rapid and simultaneous detection of both antibiotic resistance and high virulence in Klebsiella pneumoniae.

News • When good bacteria fight back

Klebsiella strain to protect against IBD gut infections

New research shows that a harmless strain of Klebsiella – discovered by chance in laboratory experiments – can eliminate infections and reduce gut inflammation in inflammatory bowel disease (IBD).

News • Standardized assessment criteria

Lost in translation: ICU experts call for universal severity score

Current scores to assess the severity of illness in ICU patients often fail in international contexts. Researchers now call for a global scoring system based on universally available data.